In the Meet Our Consultant series, Jennifer Chain, PhD, CABP, discusses her consulting journey with AABB and offers tips for emerging biotherapies professionals.
5 min read |Open Access |In Conversation
In this month’s “In Conversation” interview, Mark Sawicki, PhD, president and CEO of Cryoport Systems, discusses critical challenges facing the cell and gene therapy field and cutting-edge solutions to safeguard CGT products.
7 min read |Members Only |In Conversation
John Hagins, president and CEO of The Community Blood Center in Appleton, Wisc., and the chair of the Task Force, chatted with AABB News about the Task Force’s focus on disaster preparedness, lessons learned, challenges in disaster response and more.
7 min read |Members Only |In Conversation
In Lagos, Nigeria, motorcyclists known as blood riders dart through congested highways to deliver life-saving blood products from local blood banks to hospitals.
9 min read |Open Access |In Conversation
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
